Back to search
Intestinal Failure-associated Liver Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Intestinal Failure-associated Liver Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Intestinal Failure-associated Liver Disease trials you may qualify forA feasibility trial called PROFIT has previously shown that FMT administered endoscopically into the jejunum in patients with cirrhosis is safe and feasible and…
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-asso…
The goal of this observational (diagnostic validation) study is to validate imaging-based biomarkers for assessing liver involvement in pediatric patients with…
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…
This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodyn…
The overall purpose of this study is to determine if replacing standard soybean oil based fat emulsions with Omegaven®, a fish oil based fat emulsion, can rever…
This will be a descriptive study designed to evaluate the propensity for hospitalized pediatric patients treated adequately with Clinolipid or standard of care…
Patient Power is a patient research network and database (registry) to collect prospective information about demographics, self-reported diagnoses and medicatio…